US 8629119
Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders
granted A61PA61P21/00A61P9/00
Quick answer
US patent 8629119 (Dual targeting of MIR-208 and MIR-499 in the treatment of cardiac disorders) held by The Board of Regents of the University of Texas System expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P21/00, A61P9/00, A61P9/04, A61P9/10